Halocare 0.25mg Tablet DT
Marketer
Lifecare Neuro Products Ltd
Salt Composition
Haloperidol (0.25mg)
Overview Halocare 0.25mg Tablet DT
Halodol 0.25mg Tablets are indicated for managing schizophrenia, a mental illness characterized by distorted perceptions and behavior. Its mechanism involves inhibiting neurotransmitters impacting mood and cognition. This medication also treats psychosis, manic episodes, and severe behavioral disturbances in adults and children. Administer with or without food, consistently at the same time daily for optimal therapeutic levels. Follow your physician's prescribed dosage and duration. If a dose is missed, take it immediately upon recollection. Complete the entire treatment course, even with symptom improvement. Abrupt cessation should be avoided without consulting your doctor, as this can exacerbate symptoms. Common adverse reactions include restlessness, sleep disturbances, extrapyramidal symptoms, muscle rigidity, and cephalalgia. Report any persistent or worsening side effects to your doctor, who can offer mitigating strategies. Prior to commencing treatment, disclose any pre-existing thyroid, kidney, epileptic, Parkinson's, glaucoma, or cardiovascular conditions. Concomitant alcohol or sedative use (including cough and allergy suppressants) is contraindicated. Weight gain is a potential consequence; a balanced diet, limited high-calorie snacks, and regular physical activity are recommended.
Uses of Halocare 0.25mg Tablet DT
A chronic mental illness characterized by psychosis.
Major Benefits of Halocare 0.25mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Halocare 0.25mg Tablet DT in water before consumption. While it can be taken with or without food, consistency is key; take it at the same time each day for best results.
Common Side effects of Halocare 0.25mg Tablet DT:
- Agitation
- Extrapyramidal symptoms
- Insomnia (difficulty in sleeping)
- Muscle spasm
- Headache
How to use Halocare 0.25mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Halocare 0.25mg Tablet DT in water prior to consumption. While it can be taken with or without food, consistent timing is recommended for optimal results.
How Halocare 0.25mg Tablet DT works:
Dopamine's influence on cognition and emotion is counteracted by Halocare 0.25mg DT tablets, a standard antipsychotic medication. This effect is achieved through dopamine receptor blockade in the brain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Halocare 0.25mg delayed-release tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Halocare 0.25mg Tablet DT during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Halocare 0.25mg Tablet DT while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk with the possibility of infant harm. If this medication is necessary, careful observation of the infant for somnolence is recommended.
DrivingUNSAFE
Using Halocare 0.25mg DT tablets might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving is not advised if these effects are experienced.
KidneySAFE IF PRESCRIBED
Halocare 0.25mg tablets (DT) are generally safe for individuals with kidney disease, and no dosage modification is typically necessary. Nevertheless, patients exhibiting severe kidney impairment might require initiation with a reduced dose due to a potential increase in drowsiness.
LiverCAUTION
Patients with hepatic impairment should use Halocare 0.25mg Tablet DT cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Halocare 0.25mg Tablet DT :
NA
Facts to Know About Halocare 0.25mg Tablet DT
| Label | Value |
|---|---|
| Chemical Category | Butyrophenone analog |
| Developing Habits | No. |
| Type of Therapy | Neuroscience of the Central Nervous System |
| Actions | Conventional Antipsychotics |
3,018 People bought this recently